Hypromellose acetate succinate (HPMCAS) is a cellulose-based polymer used primarily as an enteric coating material in the pharmaceutical industry. It provides controlled drug release and enhances drug solubility, making it an essential excipient in drug formulation. Initially approved in Japan in 1987, HPMCAS has gained widespread adoption across global pharmaceutical markets.
Market Size
The Global pharma-grade hypromellose acetate succinate market was valued at USD 45 million in 2025 and is projected to reach USD 69.81 million by 2034, growing at a compound annual growth rate (CAGR) of 5.00% during the forecast period.
Regionally, the North American market was valued at USD 12.75 million in 2025 and is expected to expand at a CAGR of 4.29% from 2026 through 2034. This growth is driven by increasing demand for controlled drug delivery systems and advancements in drug formulation technologies.
Pharma Grade Hypromellose Acetate Succinate Market – View in Detailed Research Report
Market Dynamics (Drivers, Restraints, Opportunities, and Challenges)
Drivers
-
Growing Pharmaceutical Industry: Rising demand for enteric-coated formulations is driving market expansion.
-
Increasing Drug Solubility Challenges: HPMCAS enhances bioavailability, making it a preferred excipient.
-
Regulatory Approvals and Expanding Applications: Approval by major regulatory bodies (FDA, EMA, etc.) supports its widespread use.
-
Technological Advancements in Drug Formulations: Innovation in polymer-based drug delivery systems boosts demand.
Restraints
-
High Production Costs: Manufacturing and processing complexities limit widespread adoption.
-
Stringent Regulatory Requirements: Compliance with pharmaceutical regulations poses challenges for market players.
Opportunities
-
Expanding Generic Drug Market: Increasing demand for cost-effective drug formulations creates opportunities.
-
Rising Investments in Drug Research & Development: Innovation in oral solid dosage forms enhances HPMCAS application.
-
Growing Adoption in Biopharmaceuticals: Improved stability and performance in biologics drive demand.
Challenges
-
Supply Chain Disruptions: Raw material shortages and production delays impact market stability.
-
Competition from Alternative Excipients: Other polymer-based excipients pose a threat to market share.
Regional Analysis
North America
-
Leading market due to strong pharmaceutical industry presence.
-
High investment in R&D for innovative drug formulations.
Europe
-
Increasing demand for controlled-release medications.
-
Regulatory advancements support market expansion.
Asia-Pacific
-
Rapidly growing pharmaceutical sector, particularly in China and India.
-
Expanding generic drug market fuels demand.
Rest of the World
-
Emerging markets in Latin America and the Middle East show growth potential.
-
Increased healthcare expenditure supports market adoption.
Top 10 Companies in the Pharma Grade Hypromellose Acetate Succinate Market
🔟 1. Shin-Etsu Chemical Co., Ltd.
Headquarters: Tokyo, Japan
Key Offering: High-grade HPMCAS for enteric coatings
Shin-Etsu Chemical is a global leader in polymer excipients, supplying HPMCAS to major pharmaceutical manufacturers worldwide. Their product portfolio focuses on high-performance polymers that meet stringent regulatory standards for drug delivery.
Sustainability Initiatives:
- Optimizing polymer synthesis to reduce CO₂ emissions
- Investing in renewable feedstock sourcing
- Partnerships with pharmaceutical companies for green formulation development
9️⃣ 2. Ashland Global Holdings Inc.
Headquarters: Covington, Kentucky, USA
Key Offering: Medium and high-substituted HPMCAS for controlled-release tablets
Ashland’s portfolio includes advanced excipients that enhance drug solubility and stability. The company emphasizes research collaborations to innovate next-generation polymer coatings.
Sustainability Initiatives:
- Carbon-neutral manufacturing processes
- Lifecycle assessment for excipient production
- Funding academic research on sustainable polymers
8️⃣ 3. Dow Chemical Company
Headquarters: Midland, Michigan, USA
Key Offering: L, M, and H grade HPMCAS for diverse dosage forms
Dow Chemical supplies a broad range of HPMCAS grades, catering to both generic and branded pharmaceutical manufacturers. Their focus on quality and scalability supports large-volume production.
Sustainability Initiatives:
- Energy-efficient production lines
- Recycling of polymer waste streams
- Investments in green chemistry research
7️⃣ 4. BASF SE
Headquarters: Ludwigshafen, Germany
Key Offering: High-performance HPMCAS for biologics and solid dosage forms
BASF’s excipient solutions are used in both small-molecule and biologic drug development, providing enhanced solubility and protection for sensitive therapeutics.
Sustainability Initiatives:
- Reduction of water usage in polymer processing
- Partnerships with pharma companies for eco-friendly formulations
- Carbon footprint reduction targets
6️⃣ 5. Eastman Chemical Company
Headquarters: Kingsport, Tennessee, USA
Key Offering: Low- to high-substituted HPMCAS for enteric-coated tablets
Eastman’s expertise in polymer chemistry enables the production of HPMCAS with tailored properties for specific drug delivery applications.
Sustainability Initiatives:
- Use of renewable feedstocks
- Waste minimization in polymer synthesis
- Support for circular economy initiatives
5️⃣ 6. Evonik Industries AG
Headquarters: Essen, Germany
Key Offering: Advanced HPMCAS formulations for controlled-release tablets
Evonik’s portfolio includes high-grade polymers that improve drug release profiles and enhance patient compliance.
Sustainability Initiatives:
- Eco-friendly manufacturing processes
- Investment in green polymer research
- Collaboration with pharma partners on sustainable drug delivery
4️⃣ 7. DuPont de Nemours, Inc.
Headquarters: Wilmington, Delaware, USA
Key Offering: HPMCAS for enteric and controlled-release dosage forms
DuPont’s polymer solutions are used by pharmaceutical companies to meet stringent release and stability requirements.
Sustainability Initiatives:
- Reduction of energy consumption in production
- Recycling of polymer by-products
- Support for sustainable manufacturing standards
3️⃣ 8. DSM Nutritional Products
Headquarters: Heerlen, Netherlands
Key Offering: High-quality HPMCAS for oral solid dosage forms
DSM’s excipient solutions focus on enhancing drug bioavailability and patient adherence.
Sustainability Initiatives:
- Use of renewable raw materials
- Carbon-neutral production targets
- Partnerships for sustainable pharmaceutical development
2️⃣ 9. Solvay SA
Headquarters: Brussels, Belgium
Key Offering: L, M, H grade HPMCAS for controlled-release tablets and capsules
Solvay’s polymer technology supports the formulation of stable, high-performance dosage forms across the pharma industry.
Sustainability Initiatives:
- Eco-efficient polymer manufacturing
- Investment in green chemistry research
- Collaboration with pharma for sustainable excipients
1️⃣ 10. LyondellBasell Industries N.V.
Headquarters: Rotterdam, Netherlands
Key Offering: High-performance HPMCAS for enteric-coated and controlled-release formulations
LyondellBasell’s polymer solutions enable precise control over drug release profiles and improve formulation stability.
Sustainability Initiatives:
- Zero-waste manufacturing goals
- Use of bio-based feedstocks
- Partnerships for sustainable pharmaceutical solutions
Download FREE Sample Report: Pharma Grade Hypromellose Acetate Succinate Market – View in Detailed Research Report
Get Full Report: Pharma Grade Hypromellose Acetate Succinate Market – View in Detailed Research Report
🌍 Outlook: The Future of Pharma Grade Hypromellose Acetate Succinate Market
The HPMCAS market is poised for steady growth as pharmaceutical companies increasingly adopt advanced polymer excipients to improve drug performance. Technological innovations, such as precision coating techniques and scalable manufacturing processes, will drive further adoption across the globe.
📈 Key Trends Shaping the Market:
- Expansion of controlled-release drug formulations across all therapeutic areas
- Growing integration of HPMCAS in biologic and biosimilar drug development
- Advancements in sustainable polymer manufacturing and green chemistry
- Increased focus on patient-centric dosage forms and adherence solutions
For a comprehensive market analysis and detailed insights, download the full report.
- Top 10 Companies in the Global Starch-Based Bioethanol Market (2026): Market Leaders Powering Global Energy - June 5, 2026
- Top 10 Companies in the Limestone and Sandstone Market (2026): Market Leaders Shaping Global Construction - June 5, 2026
- Top 10 Companies in the (S)-1-[Bis-3,5-(Trifluoromethyl)Phenyl]Ethanol Market (2026): Market Leaders Driving Global Chiral Chemistry - June 5, 2026